Selected Grants
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
ResearchResearch Scientist · Awarded by National Institutes of Health · 2022 - 2027Exploitation of a new targetable node in the AR signaling pathway in prostate cancer
ResearchResearch Scientist · Awarded by Department of Defense · 2022 - 2025Evaluation of SGK as a therapeutic target in models of breast and prostate cancer
ResearchResearch Scientist · Awarded by LQT Therapeutics · 2021 - 2022ER and LXR as mediators of the pathobiology of hypercholesterolemia
ResearchResearch Scientist · Awarded by National Institutes of Health · 1997 - 2020Hypercholesterolemia as a modifier of the tumor microenvironment in breast cancer
ResearchResearch Scientist · Awarded by Department of Defense · 2016 - 2019Evaluation of G1 antiestrogens in models of estrogen action
ResearchPrincipal Investigator · Awarded by G1 Therapeutics Inc. · 2018 - 2019Evaluation of G1T48 in models of estrogen action
ResearchPrincipal Investigator · Awarded by G1 Therapeutics Inc. · 2017 - 2018Optimization of ERalpa-LBD-based CAR-T switch
ResearchResearch Scientist · Awarded by Cell Design Labs, Inc · 2017 - 2018Evaluation of the SERD XR5-28 in models of estrogen action
ResearchPrincipal Investigator · Awarded by G1 Therapeutics Inc. · 2016 - 2017Evaluation of G1T38 and SERD XR5-28 in hormone refractory breast cancer
ResearchPrincipal Investigator · Awarded by G1 Therapeutics Inc. · 2016 - 2017Molecular Determinants of Androgen Receptor Pharmacology
ResearchSenior Research Associate · Awarded by National Institutes of Health · 2003 - 2013External Relationships
- Adara Therapeutics
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.